668 related articles for article (PubMed ID: 22653056)
1. Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease.
Argaw AT; Asp L; Zhang J; Navrazhina K; Pham T; Mariani JN; Mahase S; Dutta DJ; Seto J; Kramer EG; Ferrara N; Sofroniew MV; John GR
J Clin Invest; 2012 Jul; 122(7):2454-68. PubMed ID: 22653056
[TBL] [Abstract][Full Text] [Related]
2. Astrocytic TYMP and VEGFA drive blood-brain barrier opening in inflammatory central nervous system lesions.
Chapouly C; Tadesse Argaw A; Horng S; Castro K; Zhang J; Asp L; Loo H; Laitman BM; Mariani JN; Straus Farber R; Zaslavsky E; Nudelman G; Raine CS; John GR
Brain; 2015 Jun; 138(Pt 6):1548-67. PubMed ID: 25805644
[TBL] [Abstract][Full Text] [Related]
3. IL-1beta regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program.
Argaw AT; Zhang Y; Snyder BJ; Zhao ML; Kopp N; Lee SC; Raine CS; Brosnan CF; John GR
J Immunol; 2006 Oct; 177(8):5574-84. PubMed ID: 17015745
[TBL] [Abstract][Full Text] [Related]
4. VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown.
Argaw AT; Gurfein BT; Zhang Y; Zameer A; John GR
Proc Natl Acad Sci U S A; 2009 Feb; 106(6):1977-82. PubMed ID: 19174516
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells stabilize the blood-brain barrier through regulation of astrocytes.
Park HJ; Shin JY; Kim HN; Oh SH; Song SK; Lee PH
Stem Cell Res Ther; 2015 Sep; 6():187. PubMed ID: 26420371
[TBL] [Abstract][Full Text] [Related]
6. Astrocyte-derived VEGF increases cerebral microvascular permeability under high salt conditions.
Deng Z; Zhou L; Wang Y; Liao S; Huang Y; Shan Y; Tan S; Zeng Q; Peng L; Huang H; Lu Z
Aging (Albany NY); 2020 Jun; 12(12):11781-11793. PubMed ID: 32568100
[TBL] [Abstract][Full Text] [Related]
7. CD8 T cell-initiated vascular endothelial growth factor expression promotes central nervous system vascular permeability under neuroinflammatory conditions.
Suidan GL; Dickerson JW; Chen Y; McDole JR; Tripathi P; Pirko I; Seroogy KB; Johnson AJ
J Immunol; 2010 Jan; 184(2):1031-40. PubMed ID: 20008293
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II controls occludin function and is required for blood brain barrier maintenance: relevance to multiple sclerosis.
Wosik K; Cayrol R; Dodelet-Devillers A; Berthelet F; Bernard M; Moumdjian R; Bouthillier A; Reudelhuber TL; Prat A
J Neurosci; 2007 Aug; 27(34):9032-42. PubMed ID: 17715340
[TBL] [Abstract][Full Text] [Related]
9. Neutralization of interleukin-9 ameliorates experimental stroke by repairing the blood-brain barrier via down-regulation of astrocyte-derived vascular endothelial growth factor-A.
Tan S; Shan Y; Lin Y; Liao S; Zhang B; Zeng Q; Wang Y; Deng Z; Chen C; Hu X; Peng L; Qiu W; Lu Z
FASEB J; 2019 Mar; 33(3):4376-4387. PubMed ID: 30694693
[TBL] [Abstract][Full Text] [Related]
10. Hypertonic saline downregulates endothelial cell-derived VEGF expression and reduces blood-brain barrier permeability induced by cerebral ischaemia via the VEGFR2/eNOS pathway.
Wang Q; Deng Y; Huang L; Zeng W; Chen S; Lv B; Jiang W; Han Y; Ding H; Wen M; Zeng H
Int J Mol Med; 2019 Sep; 44(3):1078-1090. PubMed ID: 31524227
[TBL] [Abstract][Full Text] [Related]
11. Hypertonic saline alleviates experimentally induced cerebral oedema through suppression of vascular endothelial growth factor and its receptor VEGFR2 expression in astrocytes.
Huang L; Cao W; Deng Y; Zhu G; Han Y; Zeng H
BMC Neurosci; 2016 Oct; 17(1):64. PubMed ID: 27733124
[TBL] [Abstract][Full Text] [Related]
12. Astrocytic VEGFA: An essential mediator in blood-brain-barrier disruption in Parkinson's disease.
Lan G; Wang P; Chan RB; Liu Z; Yu Z; Liu X; Yang Y; Zhang J
Glia; 2022 Feb; 70(2):337-353. PubMed ID: 34713920
[TBL] [Abstract][Full Text] [Related]
13. RGMa Participates in the Blood-Brain Barrier Dysfunction Through BMP/BMPR/YAP Signaling in Multiple Sclerosis.
Zhang L; Tang S; Ma Y; Liu J; Monnier P; Li H; Zhang R; Yu G; Zhang M; Li Y; Feng J; Qin X
Front Immunol; 2022; 13():861486. PubMed ID: 35664003
[TBL] [Abstract][Full Text] [Related]
14. [The Endothelin ET
Michinaga S
Yakugaku Zasshi; 2017; 137(10):1241-1246. PubMed ID: 28966265
[TBL] [Abstract][Full Text] [Related]
15. CLEC14A deficiency exacerbates neuronal loss by increasing blood-brain barrier permeability and inflammation.
Kim Y; Lee S; Zhang H; Lee S; Kim H; Kim Y; Won MH; Kim YM; Kwon YG
J Neuroinflammation; 2020 Feb; 17(1):48. PubMed ID: 32019570
[TBL] [Abstract][Full Text] [Related]
16. Perforin competent CD8 T cells are sufficient to cause immune-mediated blood-brain barrier disruption.
Johnson HL; Willenbring RC; Jin F; Manhart WA; LaFrance SJ; Pirko I; Johnson AJ
PLoS One; 2014; 9(10):e111401. PubMed ID: 25337791
[TBL] [Abstract][Full Text] [Related]
17. Does VEGF secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight-junction proteins in central nervous system leukemia?
Feng S; Huang Y; Chen Z
Med Hypotheses; 2011 May; 76(5):618-21. PubMed ID: 21398042
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1β induces blood-brain barrier disruption by downregulating Sonic hedgehog in astrocytes.
Wang Y; Jin S; Sonobe Y; Cheng Y; Horiuchi H; Parajuli B; Kawanokuchi J; Mizuno T; Takeuchi H; Suzumura A
PLoS One; 2014; 9(10):e110024. PubMed ID: 25313834
[TBL] [Abstract][Full Text] [Related]
19. Apelin-13 Protects against Ischemic Blood-Brain Barrier Damage through the Effects of Aquaporin-4.
Chu H; Yang X; Huang C; Gao Z; Tang Y; Dong Q
Cerebrovasc Dis; 2017; 44(1-2):10-25. PubMed ID: 28402976
[TBL] [Abstract][Full Text] [Related]
20. Endothelial Wnt/β-catenin signaling reduces immune cell infiltration in multiple sclerosis.
Lengfeld JE; Lutz SE; Smith JR; Diaconu C; Scott C; Kofman SB; Choi C; Walsh CM; Raine CS; Agalliu I; Agalliu D
Proc Natl Acad Sci U S A; 2017 Feb; 114(7):E1168-E1177. PubMed ID: 28137846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
